This article presents the science dominant themes beyond coronavirus for 2021, from the perspective of scientist from different disciplines.
The coronavirus crisis is showing us that working together is possible when the threat is direct and immediate. Let’s hope that it will open the way to drive real collaborative actions for other threats such as climate change with more indirect or distant impacts.
In 2008, it was the first time that a software virus replicating the automatic process control system of a nuclear facility was recorded. In this opinion piece, Anastasia Tolstaya, an engineer at the Institute for Cyber-Intelligence Systems, Moscow Engineering Physics Institute, in the Russian Federation, explores what can be done to prevent exposing the safety of nuclear plants, in the case of a cyber attack. Finding solutions, she argues, is not trivial.
Pharmaceutical analysis is advancing to improve drug discovery and safety. Here are five top pharmaceutical trends driving the sector today.
This interview to Michael Butter analyses how conspiracy theories are relevant to infodemic and COVID-19 related disinformation.
Sukarma Thareja shares a poem about science innovation in times of COVID19, the vaccine and the horizon of returning to “normal” life.
In this article, Vijendra Agarwal reflects on the role of collaboration in science and its recognition for awarding Nobel Prizes.
The COVID19 has accelerated digitalization and the adoption of new technologies that are having effects on the way we work.
EuroScientist wish the community merry christmas and wonderful new year 2021. In this last article, a poem from Sukarma Thareja.
Prof. Tavernarakis narrates his ambitions and challenges in his new role as Vice-President ERC and the perspectives for research in Europe.
This article shows how COVID19 triggered changes in research culture and how science and technology helped to improve our quality of life.
Interview with Peter Piot, Director of the London School of Hygiene and Tropical Medicine and Special Advisor to the President of the European Commission on the response to the coronavirus and COVID-19: how science has been feeding into policy-making?